LCI - LANNETT COMPANY （）

By Josh Beckerman Lannett Co. shares fell 27% to 50 cents as they began trading over-the-counter after their suspension from the New York Stock Exchange. The…

Lannett Company (LCI) received a notice from NYSE dated April 19, 2023, notifying that NYSE will commence proceedings to delist the stock

Lannett (LCI) on Friday said its CFO John Kozlowski would depart on May 16. Read more here.

With major economic weakness possibly lurking around the corner, investors should consider targeting stocks to sell. Specifically, market participants should note securities that feature rising short borrow fees. As the name suggests, brokerage firms charge fees to clients who borrow shares for shorting purposes. Further, the more difficult the underlying security is to borrow, the higher the fee. On paper, rising borrowing costs indicate greater demand among short sellers, which is naturally bearish for impacted enterprises. True, the risk of the contrarian wave – the short squeeze – may rise as borrowing costs go northward. However, some enterprises feature flawed financials or fundamental headwinds. Therefore, you may want to avoid the below stocks to sell. RKT Rocket Companies $7.98 LCI Lannett Company $2.09 ECOR electroCore $3.47 CVNA Carvana $9.76 GNUS Genius Brands $3.22 MARA Marathon Digital $7.47 GETY Getty Images $6.48 Rocket Companies (RKT) Source: Shutterstock While Rocket Companies (NYSE: RKT ) enjoyed a decent run this year, circumstances may sour soon.

Private equity firm Stellex makes three acquisitions to form what the buyer refers to as ''a tech-enabled risk and compliance platform.'' The post PE Firm Stellex Capital Management Acquires Fintellix, G2 and LCI appeared first on ChannelE2E: Technology News for MSPs & Channel Partners .

The platform is focused on providing risk, fraud mitigation and regulatory compliance services to theirbclients within the financial and digital commerce sectors.

TransUnion (TRU) has finalized the sale of G2 Web Services, Lundquist Consulting and Fintellix India Private Limited to an affiliate of investment firm Stellex Capital…

CHICAGO, Jan. 03, 2023 (GLOBE NEWSWIRE) -- TransUnion (NYSE: TRU) completed the previously announced sale of G2 Web Services, Inc. (“G2”), Lundquist Consulting, Inc. (“LCI”) and Fintellix India Private Limited (“Fintellix”), to an affiliate of Stellex Capital Management LLC (“Stellex”), a global, multi sector investment firm for $176 million of consideration, subject to customary purchase price adjustments.

NEW YORK--(BUSINESS WIRE)-- #acquisition--An affiliate of Stellex Capital Management LLC (“Stellex”) has acquired G2 Web Services, Inc. (“G2”), Lundquist Consulting, Inc. (“LCI”) and Fintellix India Private Limited (“Fintellix”, together with G2 and LCI, the “Platform”) from TransUnion (NYSE: TRU). The Platform is comprised of leading and tenured businesses, focusing on deploying sophisticated data-driven solutions to provide mission-critical risk, fraud mitigation, and regulatory compliance services to their

As of Tuesday, Lannett Company Inc.’s (NYSE:LCI) stock closed at $0.80, up from $0.71 the previous day. While Lannett Company Inc. has overperformed by 13.46%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, LCI fell by -52.94%, with highs and lows ranging from $1.91 to $0.38, […]

In Wednesday’s session, Lannett Company Inc. (NYSE:LCI) marked $0.71 per share, up from $0.68 in the previous session. While Lannett Company Inc. has overperformed by 3.89%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, LCI fell by -56.70%, with highs and lows ranging from $2.16 to […]

Gainers Imago BioSciences, Inc. (NASDAQ: IMGO ) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash. NeuroOne Medical Technologies Corporation (NASDAQ: NMTC ) jumped 44.5% to close at $1.20. NeuroOne, last month, received FDA 510(k) clearance to market its Evo sEEG System for less than 30 day use. OncoSec Medical Incorporated (NASDAQ: ONCS ) gained 42.2% to close at $4.85. OncoSec Medical recently announced early clinical data from an investigator-sponsored trial of TAVO in combination with Bristol-Myers Squibb’s intravenous Opdivo (nivolumab). Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO ) surged 40.3% to close at $2.47. NWTN Inc. (NASDAQ: NWTN ) jumped 38.8% to close at $7.05. SeaStar Medical Holding Corporation (NASDAQ: ICU ) shares jumped 33.6% to close at $5.25. Sotera Health Company (NASDAQ: SHC ) gained 32.9% to close at $8.00. Barclays, last week, downgraded Sotera Health from Equal-Weight to Underweight and lowered the price target from $7 to $6.

The shares of generic drugmaker Lannett Company (LCI) added ~9% on Monday after announcing a licensing deal for patents related to a pen injector device for its investigational…

TREVOSE, Pa. , Nov. 7, 2022 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI ) today announced that it has entered into an agreement with Ypsomed AG, the manufacturer and supplier of the pen injector device to be used in connection with its biosimilar insulin glargine and biosimilar insulin aspart development programs, that will provide a patent sublicense to the company and its strategic alliance partner within the HEC Group of companies (HEC). Under the agreement, Lannett and HEC will, in exchange for its financial contribution, receive a … Full story available on Benzinga.com